Swiss stocks - Factors to watch on January 17

Crispr Therapeutics AG

17/01/2024 05:33

ZURICH/BERLIN, Jan 17 - Here are some of the main
factors that may affect Swiss stocks on Wednesday:
    
    GEBERIT  GEBN.S 
    Preliminary full year results due.
    
    CREDIT SUISSE  UBSG.S 
    Spanish investment bank and asset manager Alantra  ALNTA.MC 
has hired former Credit Suisse banker Patrick Porritt as
managing director of financial institution coverage, according
to a memo seen by Reuters.
    
    SYNGENTA
    Syngenta and Corteva  CTVA.N  must face a lawsuit from the
U.S. Federal Trade Commission and a bipartisan group of states
accusing the pesticide manufacturers of unlawful efforts to curb
competition from generic rivals, a federal judge has ruled.
    
    CRISPR THERAPEUTICS  CRSP.BN 
    The U.S. health regulator has approved Vertex
Pharmaceuticals  VRTX.O  and CRISPR Therapeutics' gene therapy
to treat a rare blood disorder requiring regular blood
transfusions, in patients 12 years and older, Vertex said on
Tuesday.
    
    ECONOMY
    No major Swiss economic data scheduled.

 (Reporting by Zurich newsroom and Berlin Speed Desk)
 ((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
 
((For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German  .SDE 
All SMI constituent stocks  0#.SSMI 
DJ STOXX index  .STOXX 
Top 10 STOXX sectors  .PGL.STOXXS 
Top 10 EUROSTOXX sectors  .PGL.STOXXES 
Swiss mid-cap index  .SSMI 
Swiss all-share index  .SSHI 
Swiss market digest  .AD.S 
Sector overview  CH/SECTOR1 
All Swiss news  CH 
Swiss research news  CH-RCH   
All equity news  E 
SPEED GUIDES:   EQUITY   EQUITY/NEWS1   EUR/EQUITY   SWITZERLAND   REUTERS  ))